{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:40:22Z","timestamp":1788921622339,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.ophtha.2004.03.036","type":"journal-article","created":{"date-parts":[[2004,9,17]],"date-time":"2004-09-17T15:07:40Z","timestamp":1095433660000},"page":"1935-1942","source":"Crossref","is-referenced-by-count":84,"title":["Characteristic retinal atrophy with secondary \u201cinverse\u201d optic atrophy identifies vigabatrin toxicity in children"],"prefix":"10.1016","volume":"111","author":[{"given":"J.Raymond","family":"Buncic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Westall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole M.","family":"Panton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.Robert","family":"Munn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie D.","family":"MacKeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2004.03.036_BIB1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1055\/s-2007-979766","article-title":"Vigabatrin in childhood epilepsy","volume":"26","author":"Uldall","year":"1995","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0074-7742(02)49012-5","article-title":"Treatment of infantile spasms","volume":"49","author":"Mackay","year":"2002","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-2008-1071586","article-title":"Vigabatrin for refractory partial seizures in children with tuberous sclerosis [letter]","volume":"25","author":"Curatolo","year":"1994","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/seiz.2000.0382","article-title":"Long-term open multicentre, add-on trial of vigabatrin in adult resistant partial epilepsy","volume":"9","author":"Guberman","year":"2000","journal-title":"Seizure"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bmj.314.7075.180","article-title":"Severe persistent visual field constriction associated with vigabatrin","volume":"314","author":"Eke","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB6","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/jnnp.67.6.716","article-title":"Visual field defects associated with vigabatrin therapy","volume":"67","author":"Lawden","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB7","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1111\/j.1528-1157.1999.tb01599.x","article-title":"Characteristics of a unique visual field defect attributed to vigabatrin","volume":"40","author":"Wild","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2165\/00023210-200115030-00005","article-title":"Visual field defects with vigabatrin","volume":"15","author":"Kalviainen","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB9","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1212\/WNL.50.3.614","article-title":"Vigabatrin-associated retinal cone system dysfunction","volume":"50","author":"Krauss","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB10","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/S0161-6420(99)90345-7","article-title":"Symptomatic and asymptomatic visual loss in patients taking vigabatrin","volume":"106","author":"Daneshvar","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1014644307518","article-title":"Visual field constriction and electrophysiological changes associated with vigabatrin","volume":"104","author":"Besch","year":"2002","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1212\/WNL.55.3.347","article-title":"Separating the retinal electrophysiologic effects of vigabatrin","volume":"55","author":"Harding","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1023\/A:1014603229383","article-title":"The effects of vigabatrin on electrophysiology and visual fields in epileptics","volume":"104","author":"Comaish","year":"2002","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/adc.85.6.469","article-title":"Vigabatrin associated retinal dysfunction in children with epilepsy","volume":"85","author":"Koul","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB15","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/bmj.314.7095.1693a","article-title":"Severe persistent visual field constriction associated with vigabatrin [letter]","volume":"314","author":"Wilson","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB16","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/jnnp.70.6.787","article-title":"Visual field loss associated with vigabatrin","volume":"70","author":"Ravindran","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB17","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s004150050165","article-title":"Vigabatrin-induced optic neuropathy","volume":"244","author":"Crofts","year":"1997","journal-title":"J Neurol"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB18","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/eye.2000.83","article-title":"Vigabatrin-associated visual field defects in children","volume":"14","author":"Russell-Eggitt","year":"2000","journal-title":"Eye"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1002016531591","article-title":"Standard for clinical electroretinography (1999 update)","volume":"97","author":"Marmor","year":"1999","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1023\/A:1014656626174","article-title":"The Hospital for Sick Children, Toronto, longitudinal ERG study of children on vigabatrin","volume":"104","author":"Westall","year":"2002","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1023\/B:DOOP.0000005338.51554.e3","article-title":"Longitudinal changes in photopic OPs occurring with vigabatrin treatment","volume":"107","author":"Morong","year":"2003","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1023\/B:DOOP.0000005339.23258.8f","article-title":"Changes in the electroretinogram resulting from discontinuation of vigabatrin in children","volume":"107","author":"Westall","year":"2003","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00006324-198601000-00003","article-title":"Electrophysiological assessment of contrast sensitivity in human infants","volume":"63","author":"Norcia","year":"1986","journal-title":"Am J Optom Physiol Opt"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB24","unstructured":"Power Diva [computer program]. Version 1.0. San Francisco: Smith Kettlewell Eye Research Institute; 2004"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB25","first-page":"1261","article-title":"Field-specific visual-evoked potentials","volume":"58","author":"Harding","year":"2002","journal-title":"identifying field defects in vigabatrin-treated children. Neurology"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB26","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/0306-4522(96)00097-8","article-title":"Activity-dependent transport of GABA analogues into specific cell types demonstrated at high resolution using a novel immunocytochemical strategy","volume":"73","author":"Pow","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.ophtha.2004.03.036_BIB27","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1476-5381.1990.tb15803.x","article-title":"Development of tolerance to the effects of vigabatrin (gamma-vinyl-GABA) on GABA release from rat cerebral cortex, spinal cord and retina","volume":"100","author":"Neal","year":"1990","journal-title":"Br J Pharmacol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642004006724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642004006724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T20:52:48Z","timestamp":1549227168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642004006724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0161642004006724"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2004.03.036","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}